Fig. 4From: Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover studyPlasma cortisol following 18 mg m−2 cisplatin i.v. Timecourse of change in plasma cortisol following 18 mg m−2 cisplatin i.v. comparing placebo to each of the antiemetic treatment groups. Values presented as mean + SEM, n = 8 per group, except metoclopramide group where n = 7. Significant differences between placebo and anti-emetic treated groups: mixed linear model (*P < 0.05, **P < 0.01, *** P < 0.001)Back to article page